Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue 3, Pages 375-385
Publisher
Informa UK Limited
Online
2014-09-15
DOI
10.1586/17474124.2015.960396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: HCV genotype 3 - the new treatment challenge
- (2014) J. Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metabolic Syndrome and Cardiometabolic Risk Factors
- (2014) Emilia Papakonstantinou et al. Current Vascular Pharmacology
- Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3
- (2014) Karolina Rembeck et al. HEPATOLOGY
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- (2014) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individualization of chronic hepatitis C treatment according to the host characteristics
- (2014) Nikolaos K Gatselis WORLD JOURNAL OF GASTROENTEROLOGY
- Microbes and obesity—interrelationship between infection, adipose tissue and the immune system
- (2013) V. Hegde et al. CLINICAL MICROBIOLOGY AND INFECTION
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
- (2013) G.J. Dore et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: Final results from the STEPS trial
- (2013) D. Shoeb et al. JOURNAL OF HEPATOLOGY
- Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999–2010
- (2013) Hiram Beltrán-Sánchez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment of hepatitis C virus genotype 3-infection
- (2013) Stanislas Pol et al. LIVER INTERNATIONAL
- New therapeutic strategies in HCV: second-generation protease inhibitors
- (2013) Virginia C. Clark et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
- (2013) Yoshihide Ueda et al. PLoS One
- The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C
- (2013) Jeffrey McCombs et al. JAMA Internal Medicine
- Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
- (2012) J. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
- (2012) Vincenzo Summa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
- (2012) Khayriyyah Mohd Hanafiah et al. HEPATOLOGY
- Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant
- (2012) L. Lu et al. JOURNAL OF GENERAL VIROLOGY
- HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism
- (2012) J. Stenkvist et al. JOURNAL OF VIRAL HEPATITIS
- The pharmacogenetic background of hepatitis C treatment
- (2012) Christina Schlecker et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
- (2012) Luis F. López-Cortés et al. PLoS One
- Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
- (2012) Åsa Alsiö et al. PLoS One
- IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
- (2011) G. Fattovich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: insulin resistance and sustained virological response in hepatitis C
- (2011) M. Eslam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: epidemiology of hepatitis C genotype 6 and its management
- (2011) D. T. Chao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α2a Monotherapy
- (2011) Ahmad Amanzada et al. DIGESTIVE DISEASES AND SCIENCES
- Response to antiviral therapy in patients with genotype 3 chronic hepatitis C
- (2011) Dania Shoeb et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
- (2011) William Sievert et al. LIVER INTERNATIONAL
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- (2011) Markus Cornberg et al. LIVER INTERNATIONAL
- HIV/hepatitis C coinfection natural history and disease progression
- (2011) Maria D. Hernandez et al. Current Opinion in HIV and AIDS
- Prediction of Response to Pegylated Interferon plus Ribavirin byIL28BGene Variation in Patients Coinfected with HIV and Hepatitis C Virus
- (2010) Juan A. Pineda et al. CLINICAL INFECTIOUS DISEASES
- ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients
- (2010) Hidenori Ochi et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin
- (2010) Moises Diago et al. HEPATOLOGY
- Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus
- (2010) Stanley M. Lemon JOURNAL OF BIOLOGICAL CHEMISTRY
- Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin
- (2010) Thomas-Matthias Scherzer et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
- (2010) Michael W. Fried et al. JOURNAL OF HEPATOLOGY
- Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
- (2010) Mahmoud A. Khattab et al. JOURNAL OF HEPATOLOGY
- ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
- (2010) Jacques Fellay et al. NATURE
- HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
- (2009) Nikolai Mühlberger et al. BMC PUBLIC HEALTH
- Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin
- (2009) Michelle Martinot-Peignoux et al. HEPATOLOGY
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
- (2009) Barbara Rehermann JOURNAL OF CLINICAL INVESTIGATION
- Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
- (2009) Chia-Yen Dai et al. JOURNAL OF HEPATOLOGY
- The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
- (2009) Nabil Antaki et al. LIVER INTERNATIONAL
- Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
- (2009) Jan Peveling-Oberhag et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention
- (2009) Anoop Misra et al. Metabolic Syndrome and Related Disorders
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis
- (2008) A. ANDRIULLI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
- (2008) Marina Berenguer JOURNAL OF HEPATOLOGY
- Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3
- (2007) Hossein Poustchi et al. JOURNAL OF HEPATOLOGY
- The changing epidemiology of hepatitis C virus infection in Europe
- (2007) Juan I. Esteban et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More